Article
Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium.
BMJ open respiratory research - 24 Apr 2024
Blankestijn Jelle M, Abdel-Aziz Mahmoud I, Baalbaki Nadia, Bazdar Somayeh, Beekers Inés, Beijers Rosanne J H C G, Bloemsma Lizan D, Cornelissen Merel E B, Gach Debbie, Houweling Laura, Holverda Sebastiaan, Jacobs John J L, Jonker Reneé, van der Lee Ivo, Linders Paulien M A, Mohamed Hoesein Firdaus A A, Noij Lieke C E, Nossent Esther J, van de Pol Marianne A, Schaminee Daphne W, Schols Annemie M W J, Schuurman Lisanne T, Sondermeijer Brigitte, Geelhoed J J Miranda, van den Bergh Joop P, Weersink Els J M, de Wit-van Wijck Yolanda, Maitland-van der Zee Anke H
Abstract excerpt
BACKGROUND: Four months after SARS-CoV-2 infection, 22%-50% of COVID-19 patients still experience complaints. Long COVID is a heterogeneous disease and finding subtypes could aid in optimising and developing treatment for the individual patient. METHODS: Data were collected from 95 patients in the P4O2 COVID-19 cohort at 3-6 months after infection. Unsupervised hierarchical clustering was performed on patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.